Multiple Sclerosis – Pipeline Review, H2 2016: Ken Research Global Markets Direct’s, ‘Multiple Sclerosis – Pipeline Review, H2 2016’, provides an overview of the Multiple Sclerosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Multiple Sclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also… Read More »
